{"entity":{"type":"insider","cik":"0001615726","url":"/insider/0001615726","json_url":"/insider/0001615726.json","name":"Van der Ploeg Leonardus H.T.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":5,"first":"2018-09-27","last":"2019-06-03","span_basis":"filed_date"},"name_variants":[{"name":"Van der Ploeg Leonardus H.T.","source":"filing","n_filings":5,"first_seen":"2018-09-27","last_seen":"2019-06-03"}],"transactions":[{"id":8200968,"accession":"0001104659-19-033437","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-19-033437","line_url":"/filing/0001104659-19-033437#line-4","is_derivative":false,"issuer_cik":"0001615726","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001615726","owner_cik":"0001615726","owner_name":"Van der Ploeg Leonardus H.T.","owner_display_name":"Van der Ploeg Leonardus H.T.","owner_url":"/insider/0001615726","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.1,"price_display":"25.10","price_state":"stated","total_value":125500.0,"total_display":"125,500.00","total_whole":"125,500","shares_owned_after":42339.0,"shares_owned_after_display":"42,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider"},{"id":8200962,"accession":"0001104659-19-033437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-033437","line_url":"/filing/0001104659-19-033437#line-2","is_derivative":false,"issuer_cik":"0001615726","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001615726","owner_cik":"0001615726","owner_name":"Van der Ploeg Leonardus H.T.","owner_display_name":"Van der Ploeg Leonardus H.T.","owner_url":"/insider/0001615726","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.31,"price_display":"25.31","price_state":"stated","total_value":126550.0,"total_display":"126,550.00","total_whole":"126,550","shares_owned_after":42339.0,"shares_owned_after_display":"42,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-06-03","scope":"insider"},{"id":8093494,"accession":"0001104659-19-032725","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-19-032725","line_url":"/filing/0001104659-19-032725#line-5","is_derivative":false,"issuer_cik":"0001615726","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001615726","owner_cik":"0001615726","owner_name":"Van der Ploeg Leonardus H.T.","owner_display_name":"Van der Ploeg Leonardus H.T.","owner_url":"/insider/0001615726","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.51,"price_display":"25.51","price_state":"stated","total_value":127550.0,"total_display":"127,550.00","total_whole":"127,550","shares_owned_after":42339.0,"shares_owned_after_display":"42,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-29","filed_date":"2019-05-30","scope":"insider"},{"id":8093492,"accession":"0001104659-19-032725","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-032725","line_url":"/filing/0001104659-19-032725#line-3","is_derivative":false,"issuer_cik":"0001615726","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001615726","owner_cik":"0001615726","owner_name":"Van der Ploeg Leonardus H.T.","owner_display_name":"Van der Ploeg Leonardus H.T.","owner_url":"/insider/0001615726","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.38,"price_display":"25.38","price_state":"stated","total_value":253800.0,"total_display":"253,800.00","total_whole":"253,800","shares_owned_after":42339.0,"shares_owned_after_display":"42,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider"},{"id":7943219,"accession":"0001104659-19-002494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-002494","line_url":"/filing/0001104659-19-002494#line-1","is_derivative":false,"issuer_cik":"0001615726","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001615726","owner_cik":"0001615726","owner_name":"Van der Ploeg Leonardus H.T.","owner_display_name":"Van der Ploeg Leonardus H.T.","owner_url":"/insider/0001615726","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":42339.0,"shares_owned_after_display":"42,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-16","filed_date":"2019-01-18","scope":"insider"},{"id":6257068,"accession":"0001104659-18-066381","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-066381","line_url":"/filing/0001104659-18-066381#line-4","is_derivative":false,"issuer_cik":"0001615726","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001615726","owner_cik":"0001615726","owner_name":"Van der Ploeg Leonardus H.T.","owner_display_name":"Van der Ploeg Leonardus H.T.","owner_url":"/insider/0001615726","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38000.0,"shares_display":"38,000","price_per_share":30.09,"price_display":"30.09","price_state":"stated","total_value":1143420.0,"total_display":"1,143,420.00","total_whole":"1,143,420","shares_owned_after":42539.0,"shares_owned_after_display":"42,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-06","scope":"insider"},{"id":6541143,"accession":"0001104659-18-059105","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-18-059105","line_url":"/filing/0001104659-18-059105","is_derivative":false,"issuer_cik":"0001615726","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001615726","owner_cik":"0001615726","owner_name":"Van der Ploeg Leonardus H.T.","owner_display_name":"Van der Ploeg Leonardus H.T.","owner_url":"/insider/0001615726","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31800.0,"shares_display":"31,800","price_per_share":29.796853459119497,"price_display":"29.80","price_state":"stated","total_value":947539.94,"total_display":"947,539.94","total_whole":"947,540","shares_owned_after":71401.0,"shares_owned_after_display":"71,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-25","filed_date":"2018-09-27","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Officer (Chief Scientific Officer)","n_filings":5,"first_seen":"2018-09-27","last_seen":"2019-06-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001615726","retrieved_at":"2026-08-26T05:19:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}